田发奎,季如春,杨庭显
(青海大学附属医院 核医学科,青海 西宁 810001)
89SrC l2联合99mTc-M D P治疗转移性骨癌临床疗效的系统评价
田发奎,季如春,杨庭显
(青海大学附属医院 核医学科,青海 西宁 810001)
目的 评价氯化锶联合99mTc-亚甲基二膦酸盐(联合组)治疗我国转移性骨癌临床疗效。方法 计算机检索学术期刊网络出版总库、中国知网数据库(1994~2016年)、中国万方数据库(1999~2016年)、重庆维普中文科技期刊全文数据库(1989~2016年)及中国生物医学文献数据库(1994~2016年)数据库中关于联合组治疗我国转移性骨癌疗效的临床随机对照试验(RCT),对符合标准的RCT进行Meta分析。结果 共纳入16篇RCT,1 366例患者符合纳入标准。Meta分析结果,联合组治疗转移性骨癌的骨痛疗效、控制骨转移灶疗效、生存质量与单用氯化锶(对照组)治疗比较,差异有统计学意义(P<0.05),联合组优于对照组。两组不良反应比较,差异无统计学意义(P>0.05)。结论 在常规对症支持治疗的基础上,联合组治疗转移性骨癌临床疗效确切,且优于对照组。
转移性骨癌;联合治疗;氯化锶;99mTc-亚甲基二膦酸盐;系统评价
Abstract:Objective To evaluate the clinical effect of combination therapy with Strontium chloride and99mTc-methylene diphosphonate on metastatic bone cancer in China.Methods A comprehensive search was performed in CAJD,CNKI(1994-2016),WANFANG(1999-2016),VIP(1989-2016)and CB Mdisc(1994-2016)databases to collect the randomized controlled trials (RCTs)in which combined therapy with Strontium chloride and99mTc-methylene diphosphonate was applied to metastatic bone cancer in China.Meta-analysis was performed to analyze the RCTs.Results In the 16 RCTs which met the research standards,1,366 patients were analyzed.The meta-analysis results suggested that,compared with the Strontium chloride group,bone pain,bone metastasis control and life quality were improved significantly in the combination therapy group (P<0.05);and the adverse reactions had no significant differences between the two groups (P>0.05).Conclusions On the basis of symptomatic and supportive treatment,the effect of combined therapy of Strontium chloride and99mTc-methylene diphosphonate is positive for treatment of metastatic bone cancer,and better than that of simple Strontium chloride treatment.
Keywords:metastatic bone cancer;combined therapy;Strontium chloride;99mTc-methylene diphosphonate;systematic review
转移性骨癌在恶性肿瘤患者中多见,有研究报道50%的原发恶性肿瘤转移到骨骼[1]。恶性肿瘤发生骨转移后通常引起顽固性骨痛、骨功能障碍,甚至引发病理骨折。这给患者带来难以忍受的痛苦,严重影响生存质量。临床上常采用化疗、放疗及核素等治疗多发转移性骨癌所致的骨痛,但疗效并不理想。近年来,国内外有文献报道,氯化锶(strontium chloride,89SrCl2)及99mTc-亚甲基二膦酸盐,(99mTc-methylene diphosphonate,99mTc-MDP),别名云克,治疗转移性骨癌取了可观的疗效,且较全身化疗副作用小、经济负担相对较轻[2-3]。……